The use of an ScFv Ab (ScFv Ab) capable of recognising a disease
associated molecule (DAM) in the manufacture of a medicament for the
prevention and/or treatment of a disease condition associated with a DAM
is described. The ScFv Ab has therapeutic, diagnostic and prognostic
applications.